GSK strikes deal with US to lower prescription drug costs & boost respiratory medicine access
GSK will make most of its inhaled respiratory portfolio and other products available on a direct purchasing platform, offering savings of up to 66%
GSK will make most of its inhaled respiratory portfolio and other products available on a direct purchasing platform, offering savings of up to 66%
The company along with its subsidiaries has overall bed capacity of 8800+ beds as on 30th September, 2025
The seminar aimed to raise public awareness about inflammageing—chronic, low-grade inflammation that silently damages the body and accelerates ageing
USFDA determines Sun Pharma's Baska facility inspection classification as OAI
Company acquires People Tree Hospital Yeshwanthpur for Rs. 430 crore
The study found BIC/LEN to be statistically non-inferior to BIKTARVY, Gilead’s current standard-of-care therapy
BaseLaunch has supported 27 biotech companies across multiple modalities and indications
Subscribe To Our Newsletter & Stay Updated